Management of Alcohol Withdrawal Using CIWA Scoring
Benzodiazepines administered using a symptom-triggered approach based on CIWA-Ar scoring is the gold standard treatment for alcohol withdrawal syndrome, with long-acting benzodiazepines preferred for most patients and short-acting options for those with hepatic dysfunction or elderly patients. 1, 2
Assessment and Severity Classification Using CIWA-Ar
The Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) is the standard tool for evaluating withdrawal severity:
CIWA-Ar assesses 10 symptoms including nausea/vomiting, tremor, sweating, anxiety, agitation, tactile/visual/auditory disturbances, headache, and orientation
Important: CIWA-Ar should not be used alone for diagnosis as high scores may also occur in anxiety disorders, sepsis, hepatic encephalopathy, and severe pain 2
Treatment Algorithm Based on CIWA-Ar Scores
Mild Withdrawal (CIWA-Ar <8):
- Monitor every 4-8 hours
- No pharmacological intervention needed
- Ensure adequate hydration and electrolyte balance
Moderate Withdrawal (CIWA-Ar 8-14):
- Implement symptom-triggered benzodiazepine protocol
- Reassess CIWA-Ar score every 2-4 hours
- Can be managed in outpatient setting with close monitoring
Severe Withdrawal (CIWA-Ar ≥15):
- Immediate benzodiazepine administration
- Reassess CIWA-Ar score every 1-2 hours
- Inpatient management required, especially with history of withdrawal seizures or delirium tremens 2
Benzodiazepine Selection and Dosing
First-line options:
Long-acting benzodiazepines (preferred for most patients):
- Diazepam: 5-10 mg PO/IV every 6-8 hours
- Chlordiazepoxide: 25-100 mg PO every 4-6 hours
Short/intermediate-acting benzodiazepines (for elderly, hepatic dysfunction):
Symptom-triggered protocol:
- Administer benzodiazepines based on CIWA-Ar scores
- Results in lower total medication doses and shorter treatment duration compared to fixed-schedule dosing 2
- Continue until CIWA-Ar scores remain <8 for 24 hours
Essential Adjunctive Therapies
Thiamine supplementation:
- Administer 100-300 mg/day to all AWS patients
- Continue for 2-3 months following resolution of withdrawal symptoms
- Prevents Wernicke encephalopathy 2
Electrolyte replacement:
- Correct magnesium, potassium, and phosphate deficiencies
- Monitor glucose levels and treat hypoglycemia
For agitation not controlled by benzodiazepines:
- Haloperidol: 0.5-5 mg PO/IM every 8-12 hours
- Note: Antipsychotics should not be used as standalone treatment for AWS 2
Special Considerations
Patients with liver disease:
- Use lorazepam or oxazepam instead of long-acting benzodiazepines
- Monitor for oversedation and respiratory depression 1
Delirium tremens (typically begins 48-72 hours after last drink):
- Always requires inpatient management, often in ICU
- Aggressive benzodiazepine treatment
- IV fluids, electrolyte correction, and thiamine supplementation 2
Withdrawal seizures:
- Benzodiazepines are both treatment and prevention
- Higher CIWA-Ar scores (>15) predict increased seizure risk 3
Post-Withdrawal Management
- Consider medications to prevent relapse (acamprosate, naltrexone, disulfiram)
- Refer to specialized addiction services and support groups
- Psychiatric consultation for evaluation and long-term planning 2
Monitoring Effectiveness
Studies show that using CIWA-Ar for symptom-triggered treatment results in:
- Reduced total benzodiazepine doses (mean dose 81.4 vs. 60.3 mg) 4
- No increase in complications when properly implemented 4, 5
- Earlier identification of patients at risk for severe withdrawal 3
The CIWA-Ar has been validated across multiple settings and languages, making it a reliable tool for managing alcohol withdrawal syndrome 6.